
Mark L. Berch
Examiner (ID: 99)
| Most Active Art Unit | 1202 |
| Art Unit(s) | 1202, 1624, 1622, 1802, 2899, 1614, 1611 |
| Total Applications | 3573 |
| Issued Applications | 2301 |
| Pending Applications | 170 |
| Abandoned Applications | 1103 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4555187
[patent_doc_number] => 07820815
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-26
[patent_title] => 'Process for the preparation of chiral 8-(-3-aminopiperidin-1-yl) xanthines'
[patent_app_type] => utility
[patent_app_number] => 11/267235
[patent_app_country] => US
[patent_app_date] => 2005-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3885
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/820/07820815.pdf
[firstpage_image] =>[orig_patent_app_number] => 11267235
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/267235 | Process for the preparation of chiral 8-(-3-aminopiperidin-1-yl) xanthines | Nov 3, 2005 | Issued |
Array
(
[id] => 5591464
[patent_doc_number] => 20060040916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-23
[patent_title] => 'Carbapenem compound crystals and injection preparations'
[patent_app_type] => utility
[patent_app_number] => 11/259509
[patent_app_country] => US
[patent_app_date] => 2005-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11762
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20060040916.pdf
[firstpage_image] =>[orig_patent_app_number] => 11259509
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/259509 | Carbapenem compound crystals and injection preparations | Oct 25, 2005 | Abandoned |
Array
(
[id] => 5297361
[patent_doc_number] => 20090012287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'Process for Producing Penam Compound'
[patent_app_type] => utility
[patent_app_number] => 11/665006
[patent_app_country] => US
[patent_app_date] => 2005-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2269
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20090012287.pdf
[firstpage_image] =>[orig_patent_app_number] => 11665006
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/665006 | Process for producing penam compound useful for preparing tazobactam | Oct 24, 2005 | Issued |
Array
(
[id] => 4688988
[patent_doc_number] => 20080033169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-07
[patent_title] => 'Crystalline Form Of Cefdinir Ammonium Salt As An Intermediate For The Preparation Of Pure Cefdinir'
[patent_app_type] => utility
[patent_app_number] => 11/719599
[patent_app_country] => US
[patent_app_date] => 2005-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2516
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20080033169.pdf
[firstpage_image] =>[orig_patent_app_number] => 11719599
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/719599 | Crystalline Form Of Cefdinir Ammonium Salt As An Intermediate For The Preparation Of Pure Cefdinir | Oct 23, 2005 | Abandoned |
Array
(
[id] => 5591680
[patent_doc_number] => 20060041132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-23
[patent_title] => 'Novel triazolo pyrimidine compounds'
[patent_app_type] => utility
[patent_app_number] => 11/255838
[patent_app_country] => US
[patent_app_date] => 2005-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6113
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20060041132.pdf
[firstpage_image] =>[orig_patent_app_number] => 11255838
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/255838 | Novel triazolo pyrimidine compounds | Oct 23, 2005 | Abandoned |
Array
(
[id] => 8146750
[patent_doc_number] => 08163754
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-24
[patent_title] => 'Purine derivatives for use as adenosine A-2A receptor agonists'
[patent_app_type] => utility
[patent_app_number] => 11/576607
[patent_app_country] => US
[patent_app_date] => 2005-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32352
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/163/08163754.pdf
[firstpage_image] =>[orig_patent_app_number] => 11576607
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/576607 | Purine derivatives for use as adenosine A-2A receptor agonists | Oct 20, 2005 | Issued |
Array
(
[id] => 4916496
[patent_doc_number] => 20080097097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-24
[patent_title] => 'Process for Preparing Purine Compounds'
[patent_app_type] => utility
[patent_app_number] => 11/662536
[patent_app_country] => US
[patent_app_date] => 2005-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5137
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20080097097.pdf
[firstpage_image] =>[orig_patent_app_number] => 11662536
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/662536 | Process for Preparing Purine Compounds | Oct 9, 2005 | Abandoned |
Array
(
[id] => 5160474
[patent_doc_number] => 20070173518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-26
[patent_title] => 'CRISTALLINE AND AMORPHOUS FORM OF A TRIAZOLO (4,5-D) PYRIDIMINE COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 11/240801
[patent_app_country] => US
[patent_app_date] => 2005-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7651
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20070173518.pdf
[firstpage_image] =>[orig_patent_app_number] => 11240801
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/240801 | Cristalline and amorphous form of a triazolo (4,5-D) pyridimine compound | Oct 2, 2005 | Issued |
Array
(
[id] => 892579
[patent_doc_number] => 07345169
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-03-18
[patent_title] => 'Process for the preparation of cephalosporin antibiotic'
[patent_app_type] => utility
[patent_app_number] => 11/240382
[patent_app_country] => US
[patent_app_date] => 2005-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4061
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/345/07345169.pdf
[firstpage_image] =>[orig_patent_app_number] => 11240382
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/240382 | Process for the preparation of cephalosporin antibiotic | Oct 2, 2005 | Issued |
Array
(
[id] => 5678404
[patent_doc_number] => 20060183760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'New purine derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/238533
[patent_app_country] => US
[patent_app_date] => 2005-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23405
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20060183760.pdf
[firstpage_image] =>[orig_patent_app_number] => 11238533
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/238533 | Purine derivatives | Sep 27, 2005 | Issued |
Array
(
[id] => 566508
[patent_doc_number] => 07465720
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-12-16
[patent_title] => 'Proteasome inhibiting β-lactam compounds'
[patent_app_type] => utility
[patent_app_number] => 11/224589
[patent_app_country] => US
[patent_app_date] => 2005-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 9466
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/465/07465720.pdf
[firstpage_image] =>[orig_patent_app_number] => 11224589
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/224589 | Proteasome inhibiting β-lactam compounds | Sep 11, 2005 | Issued |
Array
(
[id] => 5739251
[patent_doc_number] => 20060009642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-12
[patent_title] => 'Methods for the synthesis of substituted purines'
[patent_app_type] => utility
[patent_app_number] => 11/223429
[patent_app_country] => US
[patent_app_date] => 2005-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15805
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20060009642.pdf
[firstpage_image] =>[orig_patent_app_number] => 11223429
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/223429 | Methods for the synthesis of substituted purines | Sep 8, 2005 | Abandoned |
Array
(
[id] => 5866293
[patent_doc_number] => 20060100424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Process for producing Cefepime and cephalosporin analogues'
[patent_app_type] => utility
[patent_app_number] => 11/221751
[patent_app_country] => US
[patent_app_date] => 2005-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1559
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20060100424.pdf
[firstpage_image] =>[orig_patent_app_number] => 11221751
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/221751 | Process for producing Cefepime and cephalosporin analogues | Sep 8, 2005 | Issued |
Array
(
[id] => 5057677
[patent_doc_number] => 20070060599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'Crystalline forms of [1S-(1alpha, 3alpha, 4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one'
[patent_app_type] => utility
[patent_app_number] => 11/222597
[patent_app_country] => US
[patent_app_date] => 2005-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6436
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20070060599.pdf
[firstpage_image] =>[orig_patent_app_number] => 11222597
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/222597 | Crystalline forms of [1S-(1alpha, 3alpha, 4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one | Sep 8, 2005 | Abandoned |
Array
(
[id] => 5656525
[patent_doc_number] => 20060142261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Crystalline anhydrous cefdinir and crystalline cefdinir hydrates'
[patent_app_type] => utility
[patent_app_number] => 11/222313
[patent_app_country] => US
[patent_app_date] => 2005-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18556
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20060142261.pdf
[firstpage_image] =>[orig_patent_app_number] => 11222313
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/222313 | Crystalline anhydrous cefdinir and crystalline cefdinir hydrates | Sep 7, 2005 | Abandoned |
Array
(
[id] => 5656827
[patent_doc_number] => 20060142563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Crystalline anhydrous cefdinir and crystalline cefdinir hydrates'
[patent_app_type] => utility
[patent_app_number] => 11/222299
[patent_app_country] => US
[patent_app_date] => 2005-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18552
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 65
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20060142563.pdf
[firstpage_image] =>[orig_patent_app_number] => 11222299
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/222299 | Crystalline anhydrous cefdinir and crystalline cefdinir hydrates | Sep 7, 2005 | Abandoned |
Array
(
[id] => 5760731
[patent_doc_number] => 20060211676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-21
[patent_title] => 'Crystalline anhydrous cefdinir and crystalline cefdinir hydrates'
[patent_app_type] => utility
[patent_app_number] => 11/221427
[patent_app_country] => US
[patent_app_date] => 2005-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18555
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 49
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20060211676.pdf
[firstpage_image] =>[orig_patent_app_number] => 11221427
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/221427 | Crystalline anhydrous cefdinir and crystalline cefdinir hydrates | Sep 7, 2005 | Abandoned |
Array
(
[id] => 5814990
[patent_doc_number] => 20060084668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Isolated valacyclovir impurity, process for the preparation of valacyclovir impurity and use as a reference standard'
[patent_app_type] => utility
[patent_app_number] => 11/221124
[patent_app_country] => US
[patent_app_date] => 2005-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4396
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20060084668.pdf
[firstpage_image] =>[orig_patent_app_number] => 11221124
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/221124 | Isolated valacyclovir impurity, process for the preparation of valacyclovir impurity and use as a reference standard | Sep 5, 2005 | Issued |
Array
(
[id] => 5739117
[patent_doc_number] => 20060009508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-12
[patent_title] => 'Compounds for the preparation of carbapenem-type antibacterial agents'
[patent_app_type] => utility
[patent_app_number] => 11/219394
[patent_app_country] => US
[patent_app_date] => 2005-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10659
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20060009508.pdf
[firstpage_image] =>[orig_patent_app_number] => 11219394
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/219394 | Compounds for the preparation of carbapenem-type antibacterial agents | Sep 1, 2005 | Issued |
Array
(
[id] => 4867476
[patent_doc_number] => 20080146535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-19
[patent_title] => 'Compositions comprising carbacephem beta-lactam antibiotics and beta-lactamase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/218841
[patent_app_country] => US
[patent_app_date] => 2005-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9490
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20080146535.pdf
[firstpage_image] =>[orig_patent_app_number] => 11218841
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/218841 | Compositions comprising carbacephem beta-lactam antibiotics and beta-lactamase inhibitors | Sep 1, 2005 | Abandoned |